Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive aripiprazole versus placebo added to clozapine for weight effects in schizophrenia
2005-001809-25Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Abilify + clozapine with Placebo + clozapine (2 arms). Primary endpoint: Mean change from baseline in body weight at Week 16. Started Nov 2005; status: completed.
02
Drugs
aripiprazoleclozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2005-001809-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001809-25.